Ervebo

BIOLOGICAL3 trials

Sponsors

ANRS, Emerging Infectious Diseases

Conditions

Ebola Virus Disease

Phase 2

Prophylaxis Vaccine Antibodies Ebola

ANRS, Emerging Infectious DiseasesEbola Virus Disease

Start: 2021-10-17End: 2022-04-30Target: 250Updated: 2021-10-15

Impact of Delay Between Administration of Inmazeb Administration and Vaccination by Ervebo on Vaccine Immune Response on Healthy Volunteers

Not yet recruitingNCT05202288

ANRS, Emerging Infectious DiseasesEbola Virus Disease

Start: 2027-01-01End: 2027-08-01Target: 132Updated: 2026-01-22

Phase 3

EBOla Post-Exposure Prophylaxis

Not yet recruitingNCT06841614

ANRS, Emerging Infectious DiseasesEbola Virus Disease

Start: 2026-09-01End: 2028-08-01Target: 160Updated: 2026-01-22